Valuation: Teva Pharmaceutical Industries Limited

Market Cap 40.56B 0 35.2B 32.96B 30.15B 56.92B 3,864B 57.67B 386B 151B 1,931B 152B 149B 6,426B P/E 2026 *
46.7x
P/E 2027 * 19.1x
Enterprise Value 52.44B 0 45.51B 42.61B 38.98B 73.59B 4,996B 74.55B 499B 196B 2,496B 197B 193B 8,307B EV / Sales 2026 *
3.16x
EV / Sales 2027 * 2.84x
Free-Float
88.59%
Yield 2026 *
-
Yield 2027 * -
1 day+0.58%
1 week-3.86%
Current month-3.86%
1 month-0.85%
3 months-2.52%
6 months-1.97%
Current year+3.57%
1 week 10,180
Extreme 10180
10,860
1 month 9,396
Extreme 9396
10,970
Current year 8,860
Extreme 8860
11,350
1 year 5,572
Extreme 5572
11,350
3 years 3,250
Extreme 3250
11,350
5 years 2,383
Extreme 2383
11,350
10 years 2,175
Extreme 2175
20,760
Manager TitleAgeSince
Chief Executive Officer 57 31/12/2022
Director of Finance/CFO 53 21/12/2019
Chief Operating Officer 52 02/06/2024
Director TitleAgeSince
Director/Board Member 69 31/12/2008
Chairman 78 05/02/2017
Director/Board Member 65 31/08/2015
Change 5-day change 1-year change 3-year change Capi.($)
+0.58%-3.86% - - 40.56B
+1.89%+3.20%+59.70%+165.18% 1,062B
-0.24%+0.45%+50.64%+52.02% 619B
-0.95%-5.26%+24.23%+65.08% 431B
+2.43%+5.29%+49.46%+40.57% 358B
+0.96%-0.39%+35.52%+40.35% 293B
+1.40%-5.06%+9.52%+10.17% 247B
-0.73%+4.44%+42.22%+66.41% 219B
+4.63%+0.10%-0.66%-43.78% 200B
-0.68%-0.32%+18.66%+66.32% 162B
Average +0.63%-1.90%+32.14%+51.37% 399.14B
Weighted average by Cap. +0.19%-0.83%+41.15%+78.27%

Financials

2026 *2027 *
Net sales 16.58B 0 14.39B 13.47B 12.33B 23.27B 1,580B 23.57B 158B 61.86B 789B 62.26B 60.91B 2,627B 17.3B 0 15.02B 14.06B 12.86B 24.28B 1,648B 24.6B 165B 64.56B 824B 64.97B 63.56B 2,741B
Net income 1.14B 0 990M 927M 848M 1.6B 109B 1.62B 10.84B 4.25B 54.28B 4.28B 4.19B 181B 2.34B 0 2.03B 1.9B 1.74B 3.28B 223B 3.32B 22.22B 8.72B 111B 8.77B 8.58B 370B
Net Debt 11.88B 0 10.31B 9.65B 8.83B 16.67B 1,131B 16.89B 113B 44.31B 565B 44.6B 43.63B 1,882B 8.61B 0 7.47B 7B 6.4B 12.08B 820B 12.24B 81.86B 32.13B 410B 32.33B 31.63B 1,364B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
07/08/26 ILA 10,450.00 +0.58% 80,697
06/08/26 ILA 10,390.00 -0.38% 3,144,670
05/08/26 ILA 10,430.00 +0.77% 974,961
04/08/26 ILA 10,350.00 -0.77% 756,460
03/08/26 ILA 10,430.00 -4.05% 936,895
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
34.81USD
Average target price
41.20USD
Spread / Average Target
+18.36%

Quarterly revenue - Rate of surprise